Exploring the therapeutic potential of GLP-1 receptor agonists in the management of obstructive sleep apnea: a comprehensive review
R., & LEADER Publication Committee on behalf of the LEADER Trial Investigators
Our multidisciplinary team includes dieticians, clinical psychologists, well-being practitioners, doctors, specialist nurses, and obesity physicians
PhGs show significant hepatoprotective potential through their multi-target mechanisms, addressing critical processes such as oxidative stress, inflammation, apoptosis, and fibrosis
In April 2026, researchers at the 23andMe Research Institute published a large genetic study in Nature examining why people respond so differently to GLP-1 For many people using Wegovy, reaching the standard maintenance dose of 2.4mg can lead to significant weight loss and improvements in overall health